SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced ...
Morning Overview on MSN
Disabling NFIL3 via CRISPR kept engineered CAR T-cells from hitting exhaustion, prolonging tumor control in animal models
Researchers at Columbia University’s Sadelain lab and University Hospital Tubingen used CRISPR gene editing to knock out the ...
SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million ...
A lab course at UB is giving undergraduate biology students hands-on experience with CRISPR, a revolutionary gene-editing technique. CRISPR allows scientists to disable or alter specific sections of ...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...
With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...
This article was written for our sponsor, Innovation Road Trip. Eradication of certain diseases, increasing crop sizes, reducing pest populations — the current and future applications of CRISPR have ...
Seek Labs’ Programmable Target Ablation Platform (PTAP), uses CRISPR-based constructs to selectively disrupt viral DNA or RNA at conserved genomic sites. Those targets are identified and continuously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results